CYP2D6 and Parkinson disease: In the subgroup analysis based on form of the disease, a significantly increased risk was found for all forms of the disease (familial, sporadic, not reported), suggesting that the presence of CYP2D6*4 polymorphism leading to poor debrisoquine metabolism is associated with an increased risk for PD regardless of the patient’s family history.